9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Evidence is inconclusive concerning the benefit of implantable cardioverter-defibrillators (ICDs) for secondary prevention of mortality in patients with Chagas' heart disease (ChHD). The aim of this study was to compare the outcomes of ChHD patients with life-threatening ventricular arrhythmias (VAs), who were treated either with ICD implantation plus amiodarone or with amiodarone alone.

          Related collections

          Author and article information

          Journal
          Europace
          Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
          Oxford University Press (OUP)
          1532-2092
          1099-5129
          May 2014
          : 16
          : 5
          Affiliations
          [1 ] Clinical Arrhythmia and Pacemaker Unit, Instituto de Cardiologia do Distrito Federal (IC-DF), Fundação Universitária de Cardiologia (FUC), AOS 02 Bloco B apto 604, Brasília, 70660-022 DF, Brazil.
          Article
          eut422
          10.1093/europace/eut422
          24481778
          ae9bcca5-fbd9-4d64-981a-161ef3bd72eb
          History

          Amiodarone,Chagas' disease,Implantable cardioverter-defibrillator

          Comments

          Comment on this article